FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema
March 25, 2020Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment
Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
Eyeforpharma Barcelona 2020 is now a free virtual event
March 25, 2020Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma
In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
Demand for hydroxychloroquine soars after Trump says it can treat coronavirus
March 25, 2020Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19
President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …
AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal
March 25, 2020Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma
Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …
Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia
March 24, 2020Manufacturing and Production Cancer, Roche, acute myeloid leukamia
Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …
Sustainability and security: How packaging is modernising pharma
March 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma
In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone
March 24, 2020Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma
Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
China approves Takeda’s treatment for ulcerative colitis and Crohn’s disease
March 24, 2020Manufacturing and Production Crohn's, Takeda, Takeda China
China’s National Medical Products Administration (NMPA) has approved Takeda’s Entyvio (vedolizumab) for the treatment of adult patients with ulcerative colitis …
COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches
March 24, 2020Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma
As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
UK begins lockdown as government announce tough measures to stop the spread of COVID-19
March 24, 2020Manufacturing and Production COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus, coronavirus pandemic, global pandemic
Last night, British Prime Minister Boris Johnson announced sweeping measures to bring Britain into a near total societal lockdown in …
FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes
March 23, 2020Sales and Marketing FDA, diabetes, jardiance, pharma
The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …
More young coronavirus patients being hospitalised in Europe and US compared to China
March 23, 2020Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus
Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people …
ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva
March 23, 2020Sales and Marketing Cabenuva, Canada, HIV, pharma
ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …
AI may help predict patient response to non-small cell lung cancer therapies
March 23, 2020Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …
US continues sanctions against Iran despite coronavirus ravaging both nations
March 23, 2020Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus
The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …
Los Angeles County and California State near lockdown after “safer-at-home” mandate is announced
March 20, 2020Medical Communications Wuhan Coronavirus, china coronavirus, coronavirus
Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home …
FDA greenlights Gilead’s Epclusa in hepatitis C patients over six years old
March 20, 2020Medical Communications, Research and Development Epclusa, Gilead, pharma
Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C …
Top Ten most popular articles on Pharmafile.com this week
March 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus
The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …
Drug launches across Europe will be affected by coronavirus
March 20, 2020Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma
The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …
New findings on influenza could help improve cancer treatments
March 20, 2020Manufacturing and Production, Medical Communications Cancer, cancer treatments, flu, flu treatments, influenza
A new study into how the body fights influenza could help improve cancer immunotherapies. Researchers at the Fox Chase Cancer …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
